Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase IIb, randomised, double-bli...

por van der Heijde, Désirée, Gensler, Lianne S, Deodhar, Atul, Baraliakos, Xenofon, Poddubnyy, Denis, Kivitz, Alan, Farmer, Mary Katherine, Baeten, Dominique, Goldammer, Nadine, Coarse, Jason, Oortgiesen, Marga, Dougados, Maxime
Publicado 2020